Latest Data & Signals Issued

Signal Type Signal Value Data
Score -4.518 13 days ( 17.38 % )
Last Price $6.16 0.90 %
High/ Low $6.05 - $6.21 8.76%
Chg 7 Days -0.243 % $6.17 $6.16
Chg 30 Days -24.76 % $8.18 $6.16
Chg 12 mos 89.38 % $3.25 $6.16
Trend - 3 mos -12.00 % Width: 41.44 %
Trend - 12 mos 66.83 % Width: 125.89 %
Pred. range - 3 mos $5.17 - $7.31 -16.07 % - 18.71 %
Pred. range - 12 mos $10.20 - $23.03 65.67 % - 274.23 %
Short MA avg 3 mos Buy Jun 28, 2024 - 4 days
Long MA avg 3 mos Sell Jun 13, 2024 - 14 days
Short/Long MA avg 3 mos Sell Jun 14, 2024 - 13 days
Short MA avg 12 mos Sell Jun 10, 2024 - 17 days
Long MA avg 12 mos Buy Jun 04, 2024 - 21 days
Short/Long MA avg 12 mos Sell Apr 25, 2024 - 48 days
Pivot Short Sell Jun 25, 2024 - 7 days
Bollinger Buy Jun 17, 2024 - 12 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics. Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell di... FULC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT